Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells
Evelyn Menares,
Felipe Gálvez-Cancino,
Pablo Cáceres-Morgado,
Ehsan Ghorani,
Ernesto López,
Ximena Díaz,
Juan Saavedra-Almarza,
Diego A. Figueroa,
Eduardo Roa,
Sergio A. Quezada and
Alvaro Lladser ()
Additional contact information
Evelyn Menares: Laboratory of Immunoncology, Fundación Ciencia & Vida
Felipe Gálvez-Cancino: Laboratory of Immunoncology, Fundación Ciencia & Vida
Pablo Cáceres-Morgado: Laboratory of Immunoncology, Fundación Ciencia & Vida
Ehsan Ghorani: University College London Cancer Institute
Ernesto López: Laboratory of Immunoncology, Fundación Ciencia & Vida
Ximena Díaz: Laboratory of Immunoncology, Fundación Ciencia & Vida
Juan Saavedra-Almarza: Laboratory of Immunoncology, Fundación Ciencia & Vida
Diego A. Figueroa: Laboratory of Immunoncology, Fundación Ciencia & Vida
Eduardo Roa: Laboratory of Immunoncology, Fundación Ciencia & Vida
Sergio A. Quezada: University College London Cancer Institute
Alvaro Lladser: Laboratory of Immunoncology, Fundación Ciencia & Vida
Nature Communications, 2019, vol. 10, issue 1, 1-12
Abstract:
Abstract Tissue-resident memory CD8+ T (Trm) cells mediate potent local innate and adaptive immune responses and play a central role against solid tumors. However, whether Trm cells cross-talk with dendritic cells (DCs) to support anti-tumor immunity remains unclear. Here we show that antigen-specific activation of skin Trm cells leads to maturation and migration to draining lymph nodes of cross-presenting dermal DCs. Tumor rejection mediated by Trm cells triggers the spread of cytotoxic CD8+ T cell responses against tumor-derived neo- and self-antigens via dermal DCs. These responses suppress the growth of intradermal tumors and disseminated melanoma lacking the Trm cell-targeted epitope. Moreover, analysis of RNA sequencing data from human melanoma tumors reveals that enrichment of a Trm cell gene signature associates with DC activation and improved survival. This work unveils the ability of Trm cells to amplify the breath of cytotoxic CD8+ T cell responses through DCs, thereby strengthening anti-tumor immunity.
Date: 2019
References: Add references at CitEc
Citations: View citations in EconPapers (3)
Downloads: (external link)
https://www.nature.com/articles/s41467-019-12319-x Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12319-x
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-019-12319-x
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().